Labcorp Holdings Inc

LH: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|XRLOCK|SZR%LOCK|f>&ts##J

Labcorp to See Flat Medicare Reimbursement as PAMA Cuts Are Delayed Again

Business Strategy and Outlook

As a leading independent diagnostic laboratory, Labcorp participates in a highly attractive duopoly that offers favorable prospects as healthcare moves toward reformed payment models, another reprieve from scheduled PAMA cuts to Medicare reimbursement, and potentially positive M&A opportunities remain plentiful.

Sponsor Center